Home
Our Coordinated Expression
Overview
Our Culture, Mission & Values
Our Commitment to Diversity, Equity & Inclusion
Message from BIO
Our People
Overview
Leadership
Board of Directors
Founders
Programs
Overview
Tamibarotene
SY-2101
SY-5609
Platform
Overview
What is Gene Control?
Publications and Abstracts
Patients
Investors & Media
Partners
Careers
Blog
Contact
Investors & Media
Investors & Media
Overview
News
Email Alerts
Press Releases
Events & Presentations
IR Calendar
Presentations
Company Info
Profile
Leadership
Contacts
Analyst Coverage
FAQ
Financial Info
Balance Sheet
Income Statement
Cash Flow
Financial Results
Annual Reports
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Filings
Quarterly Reports
Proxy
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Investor & Media Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
Financial Information
Financial Information
Overview
Balance Sheet
Income Statement
Cash Flow
Financial Results
Annual Reports
Q2 2022
Quarter Ended Jun 30, 2022
PDF
HTML
Release
Audio
Earnings Webcast
PDF
HTML
10-Q
Filing
ZIP
XLS
HTML
XBRL
Latest 10-K
View HTML
View PDF
Financials
View the latest financials
Balance Sheet
Income Statement
Cash Flow
